SB 9200, a novel agonist of innate immunity, shows potent antiviral activity against resistant HCV variants.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Morven E Cunningham Peter A C Wing Nezam Afdhal Meleri Jones |
| Publication date | May 23, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |